Ultrasound Evaluation of Breast Nodules

Rodrigo Arrangoiz MS, MD, FACS, FSSO
  • Stavros has proposed the following BIRADS categories for breast ultrasound (see Table)
Proposed BIRADS categories for breast ultrasound.
  • The American College of Radiology classification:
    • Subdivides category 4 into:
      • BIRADS 4a:
        • Which has a 2% to 10 % risk of malignancy
      • BIRADS 4b:
        • Which has a 10% to 50 % risk of malignancy
      • BIRADS 4c:
        • Which has a 50% to 95% risk malignancy
    • BIRADS 5:
      • Has 95% or greater chance of malignancy
  • In evaluating a solid sonographic nodule:
    • One should first look for any of the 10 signs of malignancy, and if even 1 of them is present:
      • The lesion cannot be considered BIRADS 3
    • The signs of malignancy are:
      • Shadowing
      • Hypoechoic echotexture
      • Spiculation
      • Angular margins
      • Thick echogenic halo
      • Microlobulation
      • Taller than wide
      • Duct extension
      • Branching pattern
      • Calcifications
  • Note that Stavros compares the echogenicity of lesions to that of breast fat, not breast parenchyma:
    • Therefore, a lesion with hypoechoic echotexture would be very hypoechoic if breast parenchyma is used as the reference
  • The hypoechoic lesion in the image does not have smooth margins but appears microlobulated
  • Regardless of whether the classification of Stavros or the American College of Radiology is used:
    • The risk of the lesion in this patient is not low enough to be considered BIRADS 3 nor high enough risk to warrant BIRADS 5:
      • Thus, it falls somewhere in the BIRADS 4 range:
        • Biopsy is required
  • References:
    • D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. 5th ed. Reston, VA: American College of Radiology; 2013
    • Jales RM, Sarian LO, Torresan R, Marussi EF, Alvares BR, Derchain S. Simple rules for ultrasonographic subcategorization of BI-RADS®-US 4 breast masses. Eur J Radiol. 2013;82(8):1231-1235.
    • Stavros AT. Breast Ultrasound. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
#Arrangoiz #Breast Surgeon #CancerSurgeon #SurgicalOncologist #MountSinaiMedicalCenter #MSMC #Miami Mexico
Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment